RECOMBINANT VACCINE AGAINST PROLIFERATIVE ENTEROPATHY IN ANIMALS
The present invention relates to a recombinant vaccine against Lawsonia intracellularis, based on a recombinant synthetic chimeric variant of membrane proteins and invasins of said bacteria. In addition, the invention discloses synthetic nucleotide sequences encoding said protein variants, recombina...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
05.10.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a recombinant vaccine against Lawsonia intracellularis, based on a recombinant synthetic chimeric variant of membrane proteins and invasins of said bacteria. In addition, the invention discloses synthetic nucleotide sequences encoding said protein variants, recombinant proteins as such, an expression cassette of said synthetic protein antigens, a transformed cell, and a method for producing said antigens, demonstrating the antigenicity and protective potential thereof against the pathogen Lawsonia intracellularis.
La presente invención provee una vacuna recombinante contra Lawsonia intracellularis basada en una variante quimérica sintética recombinante de proteínas de membrana e invasinas de dicha bacteria. Adicionalmente, la invención divulga secuencias nucleotídicas sintéticas que codifican dichas variantes proteicas, proteínas recombinantes como tales, un casete de expresión de dichos antígenos sintéticos proteicos, una célula transformada y un método para la producción de dichos antígenos, demostrando su antigenicidad y potencial protecctivo frente al patógeno Lawsonia intracellularis. |
---|---|
Bibliography: | Application Number: MX20200002283 |